We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Pharmaceutical Sciences and Drug Design

2024 Volume 4

Indirect ^18F-Labeling of Estradiol via Automated Click Chemistry: Radiochemical Development and In Vitro Evaluation


, ,
  1. Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Delhi, Delhi, India.
Abstract

Click chemistry provides a powerful method for selectively linking diverse molecular building blocks to create sophisticated molecules efficiently. Here, we report the use of copper(I)-catalyzed biorthogonal cycloaddition between alkynes and azides for the indirect incorporation of fluorine-18 into an estradiol-based compound, aimed at imaging estrogen receptors. The synthesis protocol was entirely established and refined using an automated module, with parameters adjusted to deliver the target molecule in satisfactory yield and avoid any solid formation. While the in vitro and in vivo data did not support advancement as a clinical radiotracer, the results are nonetheless important because automated systems are indispensable for producing PET tracers reliably and repeatedly under Good Manufacturing Practice standards, all while reducing radiation exposure to staff. 


How to cite this article
Vancouver
Khan A, Patel N, Verma R. Indirect ^18F-Labeling of Estradiol via Automated Click Chemistry: Radiochemical Development and In Vitro Evaluation. Pharm Sci Drug Des. 2024;4:197-211. https://doi.org/10.51847/MiQjUEL35m
APA
Khan, A., Patel, N., & Verma, R. (2024). Indirect ^18F-Labeling of Estradiol via Automated Click Chemistry: Radiochemical Development and In Vitro Evaluation. Pharmaceutical Sciences and Drug Design, 4, 197-211. https://doi.org/10.51847/MiQjUEL35m
Articles

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.